Graves' disease is one of the most common autoimmune diseases, affecting 13 million people ... Any type, size, and location of blood vessel may be involved. ...
www.aarda.org/women.html - 18k - Similar pagesGenetic differences may help explain response to multiple sclerosis treatment
News-Medical-Net Tue, 15 Jan 2008 12:16 PM PST
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
| Multiple Sclerosis Response To Treatment May Vary Depending On Patients' Genes |
Medical News Today Tue, 15 Jan 2008 1:07 AM PST
Researchers compared the DNA of multiple sclerosis (MS) patients whose symptoms were reduced by interferon beta therapy to the DNA of patients whose symptoms were not reduced, patients who continued having relapses. The scientists say they may have identified key genetic differences between the two groups of patients, according to an article published in Archives of Neurology (JAMA/Archives).
| Genetic Differences May Help Explain Response to Multiple Sclerosis Treatment |
Newswise Mon, 14 Jan 2008 8:35 PM PST
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online today that will appear in the March 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals. ...
| F.D.A. Approves Drug for Intestinal Disease |
NYTimes.com via Yahoo! Finance Tue, 15 Jan 2008 4:40 PM PST
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohn’s disease.
| FDA OKs Tysabri to Fight Crohn's Disease |
InteliHealth Tue, 15 Jan 2008 6:29 AM PST
WASHINGTON (AP) -- Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
| Biogen Idec's Tysabri wins OK for Crohn's disease |
BizJournals Tue, 15 Jan 2008 7:48 AM PST
Biotech powerhouse Biogen Idec Inc. and Irish drug firm Elan Corp. PLC have garnered U.S. approval of multiple sclerosis drug Tysabri for the treatment of certain cases of Crohn's disease, the companies report.
| Government Approves Drug for MS Patients with Crohn's Disease |
KWWL Iowa Tue, 15 Jan 2008 6:06 AM PST
WASHINGTON - The federal government is approving a treatment for multiple sclerosis patients with a severe intestinal disorder. The Food and Drug Administration has cleared Tysabri for use in patients with moderate to severe Crohn's disease who don't respond to more conventional drugs.
| FDA OKs Tysabri to treat Crohn's disease |
Moldova.org Tue, 15 Jan 2008 7:41 AM PST
The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease.The drug, approved in 2006 to treat relapsing forms of multiple sclerosis, will be used in Crohn's disease patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional therapies, the FDA said.Crohn's disease is ...
| FDA OKs Tysabri to treat Crohn's disease |
EARTHtimes.org Tue, 15 Jan 2008 6:25 AM PST
The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease. The drug, approved in 2006 to treat relapsing forms of multiple sclerosis, will be used in Crohn's disease patients with evid...
Government approves drug for MS patients with Crohn's disease
WHBF-TV Quad Cities Mon, 14 Jan 2008 10:55 PM PST
WASHINGTON (AP) - The federal government is approving a treatment for multiple sclerosis patients with a severe intestinal disorder.
Colby Cosh: Be compassionate
National Post - Toronto,Ontario,Canada
... the law recognized the usefulness of medical marijuana as a natural means of reducing pain and nausea in sufferers of cancer, multiple sclerosis or AIDS ...
See all stories on this topic
Over 5,600 people in Arizona acknowledge having multiple sclerosis. For more than 50 years, the National Multiple Sclerosis Society, Arizona Chapter, has been committed to providing the most up-to-date information on MS treatments, medications, and research.
Beating Heart Created In Laboratory
US scientists have for the first time made a beating heart in a laboratory using heart tissue from dead rats and pigs to make a framework and seeding it with live cells.The research is the work of scientists at the University of Minnesota and is published in the January 13th early online issue of Nature Medicine.
Statins Should Be Prescribed To Most People With Diabetes, UK
Most people with diabetes should be considered for treatment with statins (cholesterol drugs), according to scientists. Researchers at Oxford University reviewed 90,000 people including nearly 20,000 with diabetes and found more people would benefit from statin treatment than previously thought.Bone Marrow Cancer Made
Resistant To Treatment By Stem Cells
Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that cancer stem cells for multiple myeloma share many properties with normal stem cells and have multiple ways of resisting chemotherapy and other treatments.
No right to experimental drugs for dying patients: Supreme Court
Published: Monday January 14, 2008
Terminally ill patients have no constitutional right to gain access to experimental drugs that have yet to win federal approval, the US Supreme Court ruled Monday.
The top court refused to hear a case brought by the Abigail Alliance for Better Access to Developmental Drugs, which accuses the government's Food and Drug Administration (FDA) of violating the legal rights of the patients.
As is customary when the court declines to take up a case, the nine justices gave no explanation of their reasoning.
The decision let stand an August ruling by the federal appeals court in Washington, which said the FDA was right to refuse access to drugs that have yet to go through the lengthy process of clinical trials.
"Although terminally ill patients desperately need curative treatments ... their deaths can certainly be hastened by the use of a potentially toxic drug with no proven therapeutic benefit," the appeals court had said.
Steven Walker, who co-founded the Abigail Alliance in 2001, had urged the Supreme Court to give patients suffering incurable disease a legal redress against the "unelected, tenured career bureaucrats" of the FDA.
"The majority opinion of the appeals court suggested that this is an issue for Congress to solve. A great idea if one has a full lifetime to work on it," he wrote Friday in a Wall Street Journal opinion piece.
"The framers (of the US constitution) understood that the pursuit of life is an inalienable right that should not be abridged without due process of law."